<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154613">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01781091</url>
  </required_header>
  <id_info>
    <org_study_id>CH-2012-02</org_study_id>
    <secondary_id>2012-A1069-34</secondary_id>
    <nct_id>NCT01781091</nct_id>
  </id_info>
  <brief_title>S4 :Trial Of Fully Closed-Loop Ventilation In ICU.</brief_title>
  <acronym>S4</acronym>
  <official_title>S4 :RANDOMIZED CONTROLLED TRIAL OF FULLY CLOSED-LOOP VENTILATION IN ICU.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preliminary study to compare IntelliVent-ASV to conventional modes used from intubation to
      extubation or death in ICU patients requiring mechanical ventilation measuring duration of
      mechanical ventilation in order to design a multicenter large trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Numbers of manual adjustments</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Numbers of manual adjustments of the FULLY CLOSED-LOOP VENTILATION  device ( INTELLIVENT ASV)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sedation duration,</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ventilation parameters</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation doses</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of invasive ventilation</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Mortality</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 days mortality</measure>
    <time_frame>participants are followed until they no longer need ventilation, up to 10 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Intensive Care Patients Invasively Ventilated</condition>
  <arm_group>
    <arm_group_label>FULLY CLOSED-LOOP VENTILATION</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IntelliVent-ASV automatic mode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional modes ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional modes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>INTELLIVENT ASV  FULLY CLOSED-LOOP VENTILATION</intervention_name>
    <arm_group_label>FULLY CLOSED-LOOP VENTILATION</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventionals Modes</intervention_name>
    <arm_group_label>Conventional modes ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Unselected ICU patients invasively ventilated for less than 24 hours, with an expected
        duration of MV longer than 48 hours.

        Exclusion  criteria:

          -  broncho-pleural fistula

          -  dyshemoglobulinémia

          -  moribund patient

          -  do-not-resuscitate order

          -  chronic respiratory failure requiring long term ventilation,

          -  patient ventilated more than 24 hours before admission,

          -  pregnancy,

          -  age below 18 years,

          -  protected patients,

          -  patient already participating in the study,

          -  Cheynes-Stockes breathing.

          -  Included patients with a treatment withdrawal decision within 24 hours after
             inclusion will be excluded,

          -  patients transferred to another ICU,

          -  patients needing ECMO, patients randomized to IntelliVent having less than 20% of
             time in IntelliVent-ASV.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer</name>
      <address>
        <city>Toulon</city>
        <state>Paca</state>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anestesia e Rianimazione 2, Fondazione IRCCS Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <state>Lombardia</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 16, 2014</lastchanged_date>
  <firstreceived_date>January 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
